✦ LIBER ✦

Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies

✍ Scribed by Olaf H. Temmink; Tomohiro Emura; Michiel De Bruin; Masakazu Fukushima; Godefridus J. Peters

Book ID: 108583891
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 378 KB
Volume: 98
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2007.00477.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutic potential of purine analogue

Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies

✍ S. A. Johnson; W. Thomas 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The main purine analogues with activity against lymphoid malignancies are fludarabine, cladribine and pentostatin, all of which are active against slowly proliferating cells through their inhibition of DNA repair and therefore have significant synergistic activity with cytotoxic agents which cause D

The therapeutic potential of the novel r

The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma

✍ Luciano Mutti; Giovanni Gaudino 📂 Article 📅 2008 🏛 PAGEPress Publications 🌐 English ⚖ 63 KB

The wnt/β-catenin signaling pathway: A p

The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer

✍ Taj D. King; Mark J. Suto; Yonghe Li 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

The significance of TP53 in lymphoid mal

The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target

✍ K-John J. Cheung; Douglas E. Horsman; Randy D. Gascoyne 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB